Black Rock Inc. Aileron Therapeutics Inc Transaction History

Black Rock Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.26 - $0.69 $49,504 - $131,376	-190,401 Reduced 98.04%	3,799 $1,000
Q1 2022 May 12, 2022	SELL	$0.37 - $0.6 $3,436 - $5,572	-9,288 Reduced 4.56%	194,200 $100,000
Q4 2021 Feb 10, 2022	BUY	$0.52 - $1.06 $4,658 - $9,496	8,959 Added 4.61%	203,488 $114,000
Q3 2021 Nov 09, 2021	SELL	$0.98 - $1.31 $4,045 - $5,407	-4,128 Reduced 2.08%	194,529 $198,000
Q2 2021 Aug 11, 2021	BUY	$1.06 - $1.43 $210,576 - $284,079	198,657 New	198,657 $249,000

213

Ticker ALRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,823,600
Market Cap $227M
Description
Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advan...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.